Bio PRs. Pharmacyclics, Inc (Nasdaq: PCYC) and its

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone

Bio PRs.

Pharmacyclics, Inc (Nasdaq: PCYC) and its collaborators provided clinical and pre-clinical presentations on ibrutinib and ibrutinib combinations at the 2012 ASH Annual Meeting. Ibrutinib inhibits Bruton's tyrosine kinase (BTK), which is known to be expressed in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma (MCL), diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and multiple myeloma (MM). All ASH presentations can be found on the corporate website in the investor relations section.

"This meeting at ASH has been filled with exciting validations of ibrutinib and its potential in blood cancers. We are concluding ASH with 9 poster presentations and 9 oral presentations, of which two were included in the 'ASH Annual Press Program' and both were honored as a 'Best of ASH'," said Bob Duggan, CEO and chairman of Pharmacyclics. "We are very proud of these clinical and research accomplishments and I would like to thank all our investigators and employees for their support and continued efforts in developing this compound for patients in need. Together with our partner Janssen we have now successfully entered several pivotal Phase III trial programs and are broadly developing ibrutinib in a multitude of hematologic cancer settings. The results we have shown over the past couple of days have been very encouraging, demonstrate our commitment to a comprehensive program and we are looking forward to further emerging data in the coming year."

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) announced twelve-month follow-up data from the pivotal PACE trial of ponatinib, its investigational BCR-ABL inhibitor, in heavily pretreated patients with advanced forms of chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The study now shows that 57 percent of accelerated-phase CML patients in the trial, including 50 percent of patients with the T315I mutation, achieved a major hematologic response (MaHR), the primary end-point for patients with advanced disease in the trial.

“Patients with advanced forms of Philadelphia chromosome-positive leukemia and those who have failed currently available therapy have limited treatment options available to them,” said Hagop M. Kantarjian, M.D., chairman and professor, Department of Leukemia, University of Texas M.D. Anderson Cancer Center. “The overall prognosis is poor for patients with advanced disease.”

“The pivotal PACE trial data show that ponatinib has robust activity in heavily pretreated patients with accelerated phase CML, more than doubling their reported best prior responses to available TKI therapy,” he added. “What is equally striking is that the median time to achieve a response to ponatinib among accelerated phase patients was only three weeks and that the median duration of major hematologic response in these patients is one year.”

Accelr8 Technology Corporation (NYSE MKT: AXK) will hold its 2012 Annual Meeting of Shareholders (the "Annual Meeting") at 2:30 p.m., local time, on Wednesday, December 12, 2012, at the Warwick Hotel Denver, 1776 Grant Street, Denver, Colorado 80203.

AmbiCom Holdings, Inc. (OTCBB: ABHI), a leading designer and developer of wireless products for the medical industry and a distributor of innovative healthcare products, announced results for its first fiscal quarter.

Diagnostic Imaging International Corp. (OTCQB IIG) (PINKSHEETS IIG) is pleased to announce that on December 10, 2012, the Company closed the acquisition of Schulkyll Open MRI ("SOMRI").

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and AstraZeneca announced today a strategic alliance for the discovery and development of novel generation antisense therapeutics against five cancer targets, which includes a license to develop and commercialise ISIS-STAT3Rx, a drug Isis is currently evaluating in an early clinical trial in patients with advanced lymphomas.

IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced the presentation of clinical findings at two medical centers of the successful treatment of brain cancers and tumors using IsoRay's patented Cesium-131 (Cs-131) sutured seeds and seed sutured mesh for internal radiation therapy.

Medicago Inc. (TSX: MDG) (OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has been awarded a non-refundable contribution of up to $493,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).

Medifocus Inc. (TSX VENTURE:MFS) (OTCQX:MDFZF) (Medifocusor the Company) announces that, due to investor demand, it intends to increase the size of the non-brokered private placement of units (the Offering) announced on November 30, 2012.

MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that they will present at the 6th Annual OneMedForum in San Francisco.

Novation Holdings (OTCBB:ALZM) today announced that it has acquired Casita de los Niños, LLC, a California limited liability company doing business as Immersion House™ effective as of November 29, 2012.

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) ( http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has completed a capital raise of $4,973,075, net of finder's fee, priced at $0.37 per unit.

Sequenom, Inc. (Nasdaq: SQNM) announced today the appointments of William Welch as the Company's President and Chief Operating Officer and Dirk van den Boom as the Company's Executive Vice President, Research & Development and Chief Technology Officer, both effective immediately.

Sigma-Aldrich Corporation (Nasdaq: SIAL) was recently named to The Civic 50, a national ranking that recognizes the leading community-minded companies in the U.S. Based on a survey conducted by the National Conference on Citizenship (NCoC), a non-profit organization that champions civic leadership, and Points of Light, a non-partisan volunteer organization, The Civic 50 is the first scientific evaluation to rank companies using the criteria of their time, talent and resources to improve the quality of life where they do business.

Syneron Medical Ltd. (NASDAQ: ELOS), http://www.syneron.com, the global leader in medical aesthetic products and technologies, announced the launch of a new Sublative iD™ Focal Tip for challenging treatment areas such as the nasolabial fold ("smile lines") and periorbital rim ("around the eyes").

Z Trim Holdings, Inc. (OTC: ZTHO), a bio-technology company providing value-added ingredients to a variety of industries, announced today that it will begin manufacturing non-GMO corn products in early 2013 to meet expanding domestic and international demand.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 226

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 174

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 116

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Lummus-Versalis Deal Adds Nine Elastomer Technologies

Updated Category News Views 93

Nine elastomer technologies do not make a flashy headline, yet this is the sort of chemical-industry move that can matter long after the applause dies down. Lummus Technology and Versalis have expanded their partnership to cover nine elastomer technologies. That is the disclosed fact, and it is meaningful on its own. The release does not lay out contract value, duration,...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 62

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
AMP Tests Debt Market With €1.25 Billion Green Notes

Updated Category News Views 167

Refinancing season has arrived early at Ardagh Metal Packaging, and it is carrying a hefty €1.25 billion price tag. AMP has launched senior secured floating-rate green notes, with proceeds intended to retire two batches of secured debt due in 2028 and leave additional cash on the balance sheet for general corporate purposes, including capital expenditure. This is not...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 49

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 30

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading
Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 201

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
BetterInvesting Puts ELMD and FIVE Under a Fresh Lens

Updated Category News Views 74

Two familiar market traps are hiding in this otherwise useful announcement: mistaking a study candidate for a buy signal, and treating the word undervalued like it fell from a mountaintop. BetterInvesting has named Electromed Inc. as its “Stock to Study” and Five Below Inc. as its “Undervalued Stock” for the January-February 2027 issue of its magazine. That is...

Continue Reading

Top 5 Most Recently Viewed Articles

Balaji Srinivasan Links Bitcoin to Wealth and Health Preservation

Updated Category News Views 54

Balaji Srinivasan's Views on Bitcoin's Role Balaji Srinivasan, the former CTO of Coinbase, has been in the spotlight for his insights on how Bitcoin can help protect personal wealth. He draws a compelling comparison between Bitcoin and the pursuit of longevity in healthcare, suggesting both serve as defenses against state control over personal lives. Bitcoin as a Shield...

Continue Reading
Sequana Medical to Host Webinar on alfapump Commercial Launch

Updated Category News Views 213

Sequana Medical's Upcoming KOL Webinar on alfapump Launch Sequana Medical is set to host a Key Opinion Leader (KOL) webinar focused on the alfapump, designed for tackling recurrent and refractory ascites due to liver cirrhosis. This engaging session will take place on January 8. Experts from esteemed institutions will dive into vital discussions about the alfapump's...

Continue Reading
Qualcomm's Strategies to Navigate Competitive Market Pressures

Updated Category News Views 196

Qualcomm's Strong Market Position Despite Challenges Qualcomm Inc (NASDAQ: QCOM) has shown impressive resilience in the market, achieving significant growth largely due to its core chip business, which has seen double-digit growth. This is an encouraging sign of ongoing demand for its technology, particularly with high-end Android devices and innovations within artificial...

Continue Reading
Healthcare Providers Speak: A Study on Challenges and Care

Updated Category News Views 216

Healthcare Providers Speak: A Study on Challenges and Care Shapiro+Raj, a premier insights and strategy consultancy, has unveiled a significant study titled The Provider Perspective: Insights on Policy, Practice, and Patient Care. This comprehensive four-part series delves into the experiences of healthcare providers in the United States, highlighting their readiness to...

Continue Reading
PBOC Executes Groundbreaking Swap Operation of 50 Billion Yuan

Updated Category News Views 101

PBOC's Innovative Swap Operation The People's Bank of China (PBOC) has made waves in the financial sector by executing its very first swap operation involving a remarkable 50 billion yuan, equivalent to approximately 7.03 billion dollars. This pivotal event took place on a Monday, signifying a strategic move in China's monetary policy. Significance of the Swap Operation...

Continue Reading